These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 9398625)
21. Influence of antibodies to the hypervariable region of E2/NS1 glycoprotein on the selective replication of hepatitis C virus in chimpanzees. Kojima M; Osuga T; Tsuda F; Tanaka T; Okamoto H Virology; 1994 Nov; 204(2):665-72. PubMed ID: 7941335 [TBL] [Abstract][Full Text] [Related]
22. Immunoglobulin mimicry by Hepatitis C Virus envelope protein E2. Hu YW; Rocheleau L; Larke B; Chui L; Lee B; Ma M; Liu S; Omlin T; Pelchat M; Brown EG Virology; 2005 Feb; 332(2):538-49. PubMed ID: 15680419 [TBL] [Abstract][Full Text] [Related]
23. Broadly cross-reactive, high-affinity antibody to hypervariable region 1 of the hepatitis C virus in rabbits. Shang D; Zhai W; Allain JP Virology; 1999 Jun; 258(2):396-405. PubMed ID: 10366577 [TBL] [Abstract][Full Text] [Related]
24. Variation of hepatitis C virus load, hypervariable region 1 quasispecies and CD81 hepatocyte expression in hepatocellular carcinoma and adjacent non-cancerous liver. Young KC; Lin PW; Hsiao WC; Chang TT; Chang YC; Wu HL J Med Virol; 2002 Oct; 68(2):188-96. PubMed ID: 12210407 [TBL] [Abstract][Full Text] [Related]
25. Towards a solution for hepatitis C virus hypervariability: mimotopes of the hypervariable region 1 can induce antibodies cross-reacting with a large number of viral variants. Puntoriero G; Meola A; Lahm A; Zucchelli S; Ercole BB; Tafi R; Pezzanera M; Mondelli MU; Cortese R; Tramontano A; Galfre' G; Nicosia A EMBO J; 1998 Jul; 17(13):3521-33. PubMed ID: 9649423 [TBL] [Abstract][Full Text] [Related]
26. A structurally flexible and antigenically variable N-terminal domain of the hepatitis C virus E2/NS1 protein: implication for an escape from antibody. Taniguchi S; Okamoto H; Sakamoto M; Kojima M; Tsuda F; Tanaka T; Munekata E; Muchmore EE; Peterson DA; Mishiro S Virology; 1993 Jul; 195(1):297-301. PubMed ID: 7686313 [TBL] [Abstract][Full Text] [Related]
27. Hepatitis cRNA quasispecies complexity in patients with alcoholic liver disease. Sherman KE; Rouster SD; Mendenhall C; Thee D Hepatology; 1999 Jul; 30(1):265-70. PubMed ID: 10385665 [TBL] [Abstract][Full Text] [Related]
28. High-density lipoprotein binding rate differs greatly between genotypes 1b and 2a/2b of hepatitis C virus. Kono Y; Hayashida K; Tanaka H; Ishibashi H; Harada M J Med Virol; 2003 May; 70(1):42-8. PubMed ID: 12629642 [TBL] [Abstract][Full Text] [Related]
29. Presence of multiple genotype-specific antibodies in patients with persistent infection with hepatitis C virus (HCV) of a single genotype: evidence for transient or occult superinfection with HCV of different genotypes. Toyoda H; Fukuda Y; Hayakawa T; Kumada T; Nakano S; Takamatsu J; Saito H Am J Gastroenterol; 1999 Aug; 94(8):2230-6. PubMed ID: 10445555 [TBL] [Abstract][Full Text] [Related]
31. Quasispecies nature of hepatitis C virus (HCV) in patients with chronic hepatitis C with mixed HCV subtypes. Toyoda H; Fukuda Y; Nakano I; Katano Y; Takayama T; Kumada T; Nakano S; Takamatsu J; Saito H; Hayakawa T J Med Virol; 1998 Feb; 54(2):80-5. PubMed ID: 9496363 [TBL] [Abstract][Full Text] [Related]
32. E2 quasispecies specificity of hepatitis C virus association with allografts immediately after liver transplantation. Hughes MG; Rudy CK; Chong TW; Smith RL; Evans HL; Iezzoni JC; Sawyer RG; Pruett TL Liver Transpl; 2004 Feb; 10(2):208-16. PubMed ID: 14762858 [TBL] [Abstract][Full Text] [Related]
33. Drift in the hypervariable region of the hepatitis C virus during 27 years in two patients. Gao G; Buskell Z; Seeff L; Tabor E J Med Virol; 2002 Sep; 68(1):60-7. PubMed ID: 12210431 [TBL] [Abstract][Full Text] [Related]
34. High titers of antibodies inhibiting the binding of envelope to human cells correlate with natural resolution of chronic hepatitis C. Ishii K; Rosa D; Watanabe Y; Katayama T; Harada H; Wyatt C; Kiyosawa K; Aizaki H; Matsuura Y; Houghton M; Abrignani S; Miyamura T Hepatology; 1998 Oct; 28(4):1117-20. PubMed ID: 9755251 [TBL] [Abstract][Full Text] [Related]
35. Complexity of the HVR-1 quasispecies and disease activity in patients with hepatitis C. Kumagai N; Kaneko F; Tsunematsu S; Tsuchimoto K; Tada S; Saito H; Hibi T Eur J Clin Invest; 2007 Jul; 37(7):566-72. PubMed ID: 17576208 [TBL] [Abstract][Full Text] [Related]
36. Changes in hypervariable region 1 of the envelope 2 glycoprotein of hepatitis C virus in children and adults with humoral immune defects. Gaud U; Langer B; Petropoulou T; Thomas HC; Karayiannis P J Med Virol; 2003 Mar; 69(3):350-6. PubMed ID: 12526045 [TBL] [Abstract][Full Text] [Related]
37. Characterization of hypervariable region in hepatitis C virus envelope protein during acute and chronic infection. Higashi K; Tsukiyama-Kohara K; Tanaka T; Tanaka E; Kiyosawa K; Kohara M Arch Virol; 2005 May; 150(5):883-98. PubMed ID: 15662481 [TBL] [Abstract][Full Text] [Related]
38. Mode of HCV infection examined by polymorphism of hypervariable region-1 in cases of acute hepatitis C after accidental exposure to blood-borne pathogens. Takeda T; Tatsumi N; Nakayama Y; Yasuda T; Nishiguchi S; Seki S J Med Virol; 2005 Jan; 75(1):35-41. PubMed ID: 15543585 [TBL] [Abstract][Full Text] [Related]
39. Multiple sequence-reactive antibodies induced by a single peptide immunization with hypervariable region 1 of hepatitis C virus. Zhou YH; Moriyama M; Esumi M Virology; 1999 Apr; 256(2):360-70. PubMed ID: 10191201 [TBL] [Abstract][Full Text] [Related]
40. HIV infection and antiretroviral therapy: effect on hepatitis C virus quasispecies variability. Shuhart MC; Sullivan DG; Bekele K; Harrington RD; Kitahata MM; Mathisen TL; Thomassen LV; Emerson SS; Gretch DR J Infect Dis; 2006 May; 193(9):1211-8. PubMed ID: 16586356 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]